Last €2.63 EUR
Change Today +0.078 / 3.06%
Volume 0.0
As of 10:01 AM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael P. Miller

Former Executive Officer, VIVUS Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

57--
As of Fiscal Year 2013

Background*

Mr. Michael P. Miller, also known as Mike, has been Senior Vice President of U.S. Commercial at Jazz Pharmaceuticals Public Limited Company since April 2014. Mr. Miller began his industry career with Syntex Laboratories (Roche Holding), where spent 13 years in sales and marketing. Mr. Miller served as Senior Vice President and Chief Commercial Officer of VIVUS Inc. from April 2010 to January 16, 2014 and was an Executive Officer from January 16, 2014 to February 14, ...

Read Full Background

Corporate Headquarters*

351 East Evelyn Avenue
Mountain View, California 94041

United States

Phone: 650-934-5200
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
University of San Francisco
MBA
San Francisco State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIU:GR €2.63 EUR +0.078

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Rajat Rai Chief Executive Officer
Akorn, Inc.
$250.0K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Jeffrey M. Yordon Founder, Chairman and Chief Executive Officer
Sagent Pharmaceuticals, Inc.
$615.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIVUS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.